In a recent study, patients were either treated with a genetically engineered heart drug or didn't receive the drug. Those that received the drug were able to walk on a treadmill for 26 seconds longer than those not receiving any treatment and showed no side effects. Select the explanation for why one would NOT conclude that this drug is an effective treatment for heart disease?

Question

BlackTom AI · Accepted Answer

Correlation does not equal causation, and study design, statistical and clinical significance, and generalizability must all be assessed before declaring effectiveness.

1) Relevant knowledge points and concepts
- Randomization, control groups, and blinding: needed to reduce bias and confounding.
- Statistical significance vs clinical significance: a numeric difference can be statistically significant yet clinically trivial.
- Sample size and power: small samples can yield unreliable estimates and large variability.
- External validity and follow-up duration: short-term gains or a narrowly selected population may not generalize or persist.
- Measurement and reporting bias, placebo effect, and adverse-event surveillance: all can distort apparent benefit.

2) Step-by-step reasoning
- The reported 26-second longer treadmill time is an observed difference, but without knowing randomization or blinding, confounders (e.g., fitter patients getting the drug) could explain it.
- If the study lacked adequate sample size or reported no p-value/confidence interval, the difference may be due to chance.
- Even if statistically significant, a 26-second improvement might not be clinically meaningful for heart-disease outcomes (mortality, hospitalization, quality of life).
- Short follow-up or incomplete adverse-event monitoring could miss late harms; absence of observed side effects in a small or brief study does not prove safety.
- Selection bias, measurement error, or sponsor influence could further invalidate conclusions.

3) Calculations
- No numerical calculations are required here; assessment depends on study parameters (p-values, CIs, sample size), which are not provided.

4) Why "All of the answers provided are correct" is correct
- Because multiple independent methodological and interpretive problems (confounding, inadequate power, lack of clinical relevance, limited follow-up, etc.) could each justify withholding the conclusion that the drug is effective. If the original multiple-choice listed such limitations individually, then selecting “All of the answers provided are correct” correctly acknowledges that every listed concern is valid.

5) Why the individual alternative choices (the listed concerns) would be insufficient alone
- Each single concern (e.g., small sample, small effect size, no randomization) is a valid reason to doubt efficacy; but since more than one concern likely applies, the composite choice covers them all.

Conclusion: Given the multiple potential methodological and interpretive flaws that could explain the 26-second difference and the absence of reported harms, the correct selection is “All of the answers provided are correct,” which matches the provided answer.

类似问题

Multiple Choice: In which of the following cases would a randomized controlled trial be required to show efficacy of a probiotic supplement?

Which phase of clinical trials primarily aims to evaluate the efficacy and optimal dose of a new treatment in patients with the target disease?

Why is Australia an attractive location for conducting Phase I clinical trials?

Which member of the clinical trial team is responsible for the overall conduct of the trial at a study site?

How long do Phase III clinical trials typically run?

Which clinical trial design involves assigning participants to different treatment groups, where each group receives only one treatment throughout the study?

Adverse events are difficulties that participants reported about the interventions provided in the study. These are listed in the Results section. Based on what was reported in final paragraph of the results section, select from the list below which adverse event were reported by participants.

What is the typical probability of success for a drug in Phase 1 trials ?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单